Serial Number | 79366831 |
Word Mark | CADENCE |
Filing Date | Wednesday, January 18, 2023 |
Status | 654 - REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED |
Status Date | Tuesday, September 23, 2025 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Goods and Services | Diagnostic preparations for medical and veterinary use or purposes; Medical diagnostic reactants for medical and veterinary diagnosis of diseases; diagnostic preparations for medical use for sale in kit form; diagnostic preparations for medical purposes; Biological indicators for medical diagnosis, namely, for detecting and diagnosing cancer; veterinary diagnostic reagents; Diagnostic reagents in kit form for conducting molecular biology assays for medical or veterinary purposes; Diagnostic reagents for medical or veterinary purposes; Diagnostic reagents for use in diagnostic tests for medical or veterinary purposes; pharmaceutical preparations for the treatment of disorders of the metabolic system; medical diagnostic reagents for testing of body fluids; Medical diagnostic assays that test for genetic anomalies for medical use; Diagnostic preparations for medical use; Biochemical preparations for diagnostic use for detecting and diagnosing cancer; Diagnostic preparations for medical purposes; Diagnostic agents for pharmaceutical use in the medical field; Test reagents for medical diagnosis, namely, disease testing; diagnostic biomarker reagents for medical purposes; Chemical preparations for diagnostic medical purposes, namely, for detecting and diagnosing cancer; Chemical preparations for use in medical diagnostics, namely, nucleic acid analysis; Chemical preparations for detecting genetic and epigenetic predispositions for medical purposes; Medical diagnostic reagents for analysis of body fluids; Synthetic deoxyribonucleic acid and synthetic ribonucleic acid for medical use, namely, for detecting and diagnosing cancer; nucleic acid amplification reagents for medical use; all of the foregoing related to cancer screening and diagnostic tests |
Goods and Services | Medical diagnostic services, namely, testing and analysis; medical testing services relating to the diagnosis and treatment of disease; medical analysis services for the diagnosis of cancer; Medical services, namely, nucleic acid analysis for cancer diagnosis and prognosis; performing diagnosis of diseases; medical services for the diagnosis of conditions of the human body; genetic testing of animals for diagnostic or treatment purposes; medical laboratory services related to the treatment of patients; Medical advisory services in the field of oncological diseases; medical analysis for the diagnosis and treatment of persons; Medical services, namely, health risk assessment surveys; health-care services for treating and detecting cancer; genetic testing for medical purposes; Medical services, namely, nucleic acid screening for medical purposes; Medical analysis services for diagnosing and detecting cancer; medical screening; Health screening services in the field of cancer; all of the foregoing related to cancer screening and diagnostic tests |
Goods and Services | Medical diagnostic apparatus for detecting and diagnosing cancer; Medical diagnostic instruments for analysis of body fluids; Biomedical testing apparatus for RNA, DNA and protein biomarkers testing; Medical diagnostics instruments in the nature of apparatus for testing RNA, DNA and protein biomarkers; medical instruments for infectious disease testing; Medical diagnostic testing apparatus for sale in kit form for testing RNA, DNA and protein biomarkers for diagnosing and detecting cancer; Medical diagnostic apparatus for testing RNA, DNA and protein biomarkers for diagnosing and detecting cancer; Diagnostic in-vitro diagnostic testing apparatus for medical use for diagnosing and detecting cancer; Medical diagnostic testing apparatus for use in molecular biology procedures, namely, testing DNA, RNA and protein biomarkers for diagnosing and detecting cancer; Diagnostic apparatus for blood tests for medical use; all of the foregoing related to cancer screening and diagnostic tests |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Monday, April 10, 2023 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
US Class Codes | 026, 039, 044 |
Class Status Code | 6 - Active |
Class Status Date | Monday, April 10, 2023 |
Primary Code | 010 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Monday, April 10, 2023 |
Primary Code | 044 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | MIRXES PTE. LTD. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 24 - NOT AVAILABLE |
Address | SG |
Event Date | Event Description |
Monday, April 10, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Friday, April 14, 2023 | APPLICATION FILING RECEIPT MAILED |
Thursday, April 6, 2023 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
Tuesday, October 17, 2023 | ASSIGNED TO EXAMINER |
Thursday, October 19, 2023 | NON-FINAL ACTION WRITTEN |
Friday, October 27, 2023 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
Friday, October 27, 2023 | REFUSAL PROCESSED BY MPU |
Wednesday, November 22, 2023 | REFUSAL PROCESSED BY IB |
Friday, October 20, 2023 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
Friday, April 26, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Friday, April 26, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Friday, April 26, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Friday, April 26, 2024 | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED |
Friday, April 26, 2024 | TEAS VOLUNTARY AMENDMENT RECEIVED |
Tuesday, April 30, 2024 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
Tuesday, April 30, 2024 | LETTER OF SUSPENSION E-MAILED |
Tuesday, April 30, 2024 | SUSPENSION LETTER WRITTEN |
Wednesday, September 4, 2024 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
Wednesday, September 4, 2024 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
Friday, September 20, 2024 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
Monday, January 27, 2025 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
Wednesday, February 26, 2025 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
Wednesday, August 27, 2025 | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
Tuesday, September 23, 2025 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |